Skip to content Skip to footer

Triple Therapy Momentum: Caterina Brindicci of AstraZeneca on Breztri in Asthma

Shots:   AstraZeneca is exploring the potential of Breztri Aerosphere in uncontrolled asthma, aiming to address the large proportion of patients who remain symptomatic on standard dual therapy and improve lung function and quality of life.  Findings from the KALOS and LOGOS Phase III trials revealed meaningful lung function gains and a 14% reduction in severe exacerbations versus dual ICS/LABA therapy, highlighting the promise of triple…

Read more

UK Biotech Day 2026 | May 27-28 | London, UK

UK Biotech Day is a leading event for the UK life sciences sector, bringing together executives and R&D scientists from pharma, biotech, medtech, techbio, investors, lawyers, patent attorneys, CROs, CDMOs, accountants, bankers, executive search agencies, and more. Serving as a global gateway, the event connects the UK ecosystem with international partners to drive strategic collaborations…

Read more

9th Annual Corporate Compliance & Transparency in Life Sciences Conference

Where compliance leaders, legal experts, and industry innovators come together to shape the future of ethical and transparent healthcare. What Makes This Event Unmissable? 20+ Thought Leaders. One Powerful Stage. Hear from leading compliance officers, legal advisors, policy experts, and life sciences executives as they share real-world insights on evolving regulatory expectations, transparency frameworks,…

Read more

Reimagining Migraine Treatment: Alon Ironi of Theranica on Nerivio’s Journey to Nationwide Coverage 

Shots:  What started as a father’s determination to find a better solution has grown into a widely reimbursed therapy. Along the way, strong clinical evidence, early physician support, and carefully designed payer pilots helped unlock nationwide coverage, reaching nearly 130 million lives across Blue Cross Blue Shield plans.  In this conversation, Alon explains how Nerivio’s dual acute and preventive…

Read more

From Denials to Decisions: Dr. Wael Khouli of Authsnap on AI-Powered Healthcare Appeals 

Shots:  Did you know that nearly 15–20% of healthcare claims in the U.S. are denied on first submission, creating billions of dollars in administrative costs and forcing providers into complex, time-consuming appeals processes that strain revenue cycles, clinical staff, and patient care continuity?    Authsnap is an AI healthcare technology company helps providers manage insurance denials and…

Read more

ISPE Singapore Conference & Exhibition 2026 | August 19-21 | Suntec Singapore

The ISPE Singapore Affiliate Conference & Exhibition is one of the largest and most respected events for bio & pharmaceutical manufacturing professionals. The annual meeting highlights best practices and services – from manufacturing facility design to finished product. Whether joining onsite in Singapore or on-demand, this is your opportunity to gather the latest updates and…

Read more

Bridging Innovation and Clinical Reality: Shalabh Gupta, CEO of Unicycive Therapeutics, on the Future of Biotech

Shots  Cross-industry lessons from technology, design thinking, and startups can reshape drug development by encouraging faster iteration, disciplined decision-making, and a stronger focus on real patient needs, unlocking innovations that traditional biotech models may overlook.    Clinical experience and thoughtful engagement with the U.S. Food and Drug Administration highlight the importance of patient insights, transparent…

Read more

CPHI Middle East 2026 | 11-13 May, Riyadh

After a breakout 2024 edition welcoming 30,000+ visitors from 100+ countries, CPHI Middle East gears up for bigger impact in 2026. Expect extensive networking, direct market access, latest insights on regulatory developments and pharmaceutical innovations, and a comprehensive range of products and services spanning the entire pharmaceutical supply chain. Register Now

Read more

Vueway Expands Pediatric Use: Alberto Spinazzi Shares Bracco Group’s Vision 

Shots:  The EU approval of Vueway for neonates, infants, and toddlers is a milestone for pediatric imaging as it allows high-quality MRI imaging at half the GBCA dose, supporting reduced gadolinium exposure in vulnerable young patients  Vueway’s gadopiclenol demonstrates safety and diagnostic performance by offering high stability, low dissociation risk, and 2.5–4× greater relaxivity than other macrocyclic GBCAs, enabling effective imaging…

Read more

Post-Conference Highlights | 2026 ViVE | Feb 22–25 | Los Angeles, CA

ViVE 2026 in Los Angeles convened policymakers, health system executives, payers, technologists, investors, and founders at a pivotal moment for healthcare. Across three days, discussions moved decisively from digital ambition to operational accountability. As the official Media Partner, PharmaShots presents a comprehensive review of the sessions, speakers, and strategic insights that defined ViVE 2026. Day…

Read more